| HOME >> BIOLOGY >> TECHNOLOGY |
Total assets 973,475 966,969 137,902
Liabilities
Current liabilities
Accounts payable 1,693 1,917 273
Deferred grant income 374 374 53
Accrued expenses and other payables 22,626 22,968 3,276
Income tax payable -- 4,962 708
Other current liabilities 67 68 10
Total current liabilities 24,760 30,289 4,320
Deferred grant income 3,526 3,433 490
Other liabilities 848 824 117
Total liabilities 29,134 34,546 4,927
Commitments and contingencies
Minority interests 549 472 67
Shareholders' equity
Share capital - ordinary shares
US$0.0001 par value, 500,000,000
shares authorized, 152,099,155
shares issued and outstanding as
of December 31, 2007 and March
31, 2008 122 122 17
Additional paid-in capital 917,527 918,388 130,974
Accumulated other comprehensive loss (48,338) (80,790) (11,522)
Retained earnings 74,481 94,231 13,439
Total shareholders' equity 943,792 931,951 132,908
Total liabilities and shareholders'
equity 973,475 966,969 137,902
3SBio Inc. and subsidiaries
Unaudited quarterly consolidated statements of income
(expressed in thousands, except per share , per ADS and other share and
ADS data)
'/>"/>
| SOURCE 3SBio Inc. Copyright©2008 PR Newswire. All rights reserved |